4[3]Bond W W,Heritage I D,Fcores G H,et al.Inactivation of hepatitis B virus by intermediati-to-high-level disinfectant chemicals[J].J Clin Microbiol,1983,18(2):535.
5[4]Kobayash H,Suzuki T,Kinoshita N,et al.Susceptibility of hepatitis B virus to disintectants or hear[J].J Clin Microbiol,1984,20(1):214.
6[5]Krogsgaard K,Imano M,Ishikawa S,et al.Delta infection and hepatitis B virus replication in Danish patients with fulminant hepatitis B[J].Scand J Infec Dis,1988,20(1):127.
7Zoulim F,Capel F, Berthillon P, et al. Clinical and virological evaluation of the detection of pre S1 and pre S2 antigens in serum from patients with chronic hepatitis B [ J]. Gastroenterol Clin Biol, 1995, 19(12) :970.
8Alberti A, Cavalletto D, Chemello L, et al. Fine spesificity of human antibody response to the domain of hepatitis B vim[J]. Hepatology,1990,12(2) : 199.
9Klinkert MQ,Theilmann L,Pfaff E, et al. Pre S1 antigens and antibodies early in the course of acute hepatitis B virus infection[ J] .J Virol,1986,58(2) :522.
10Theilmann L, Klinkert MQ, Gmelin K, et al. Detection of Pie S1 proteins in serum and liver of HBsAg-positive patients: A new marker for hepatitis B virus infection[J]. Hepatology, 1986,6(2):186.
1Jing You Lin Zhuang Bao Zhang Tang Wei Bo Yang Su Ying Ding Wu Li Rong Xue Wu Hong Li Zhang Yan Mei Zhang Shao Ming Yan Lu Zhang ~1Department of Infectious Diseases,The First Affiliated Hospital of Kunming Medical College,Kunming 650032,Yunnan Province,China ~2Departrnent of Hepatology,Kunming Third Municipal People’s Hospital,Kunming 650041,Yunnan Province,China.A randomized controlled clinical trial on the treatment of Thymosin-a1 versus interferon-α in patients with hepatitis B[J].World Journal of Gastroenterology,2001,7(3):411-414. 被引量：48
